Nano-X Imaging Ltd. Form 6-K Summary
Business Context and Reporting Period
Nano-X Imaging Ltd. furnished this Form 6-K for February 2021, reporting the results of its Special General Meeting of Shareholders held on February 9, 2021. All proposed resolutions were approved by the required majorities.
Approved Corporate and Compensation Matters
- Executive officer and director compensation policy.
- Equity compensation plan for executive officers and directors.
- Additional cash compensation for directors serving on board committees.
- Appointment and compensation of Dan Suesskind and Noga Kainan as external directors under Israeli law.
- Amendment to CEO and Chairman Ran Poliakine’s employment agreement concerning his cash bonus entitlement.
- Additional compensation for Dr. Floyd Katske for services unrelated to his director duties.
- Designation and additional compensation of Erez Melzer as a designated director under the compensation policy.
Financial Metrics and Material Changes
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics. It also does not report a comparable-period change or financial guidance.
Outlook, Risks, and Unusual Items
The filing is limited to shareholder-meeting approvals and does not include management outlook, operating risks, contingencies, or updated business guidance. The approved compensation arrangements and director appointments are the principal governance-related developments.
Key Facts to Verify
- Detailed terms and amounts of the approved compensation, bonus, equity, and director arrangements in the December 31, 2020 proxy statement.
- Effective dates and service terms for the external directors and designated director.
- Any subsequent filings describing implementation of the approved compensation policy or equity plan.
- The filing’s incorporation by reference into the Company’s Form S-8 registration statement, File No. 333-248322.